GeneDx Holdings Corp. Class A Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for WGS, updated each market day.
WGS AI Sentiment
AI sees no strong directional signal for GeneDx Holdings Corp. Class A Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About GeneDx Holdings Corp. Class A Common Stock
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Sector
Exchange
Market Cap
$1,758,788,776
Cap Tier
Employees
1,300
Headquarters
STAMFORD, CT
Listed Since
July 23, 2021
Website
WGS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
WGS Volatility
GeneDx Holdings Corp. Class A Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
